A detailed history of Ballast, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ballast, Inc. holds 3,641 shares of MRK stock, worth $370,945. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,641
Previous 3,673 0.87%
Holding current value
$370,945
Previous $454,000 9.03%
% of portfolio
0.12%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$111.15 - $128.97 $3,556 - $4,127
-32 Reduced 0.87%
3,641 $413,000
Q2 2024

Jul 15, 2024

BUY
$123.8 - $132.96 $4,456 - $4,786
36 Added 0.99%
3,673 $454,000
Q4 2023

Jan 18, 2024

BUY
$100.18 - $109.02 $12,422 - $13,518
124 Added 3.53%
3,637 $396,000
Q3 2023

Oct 18, 2023

BUY
$102.95 - $114.33 $2,676 - $2,972
26 Added 0.75%
3,513 $361,000
Q2 2023

Jul 19, 2023

BUY
$108.61 - $118.38 $378,723 - $412,791
3,487 New
3,487 $402,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ballast, Inc. Portfolio

Follow Ballast, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ballast, Inc. with notifications on news.